about
Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.The current status, challenges, and future developments of new tuberculosis vaccines.New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting Innate-Like T Cells in Tuberculosis.
@en
Targeting Innate-Like T Cells in Tuberculosis.
@nl
type
label
Targeting Innate-Like T Cells in Tuberculosis.
@en
Targeting Innate-Like T Cells in Tuberculosis.
@nl
prefLabel
Targeting Innate-Like T Cells in Tuberculosis.
@en
Targeting Innate-Like T Cells in Tuberculosis.
@nl
P2860
P356
P1476
Targeting Innate-Like T Cells in Tuberculosis
@en
P2093
Shouxiong Huang
P2860
P356
10.3389/FIMMU.2016.00594
P577
2016-12-21T00:00:00Z